BIOVIE INC. (BIVI, BIVIW)

Earlier extract: iates and certain related parties, beneficially owning more than 9.99% of our outstanding shares of Common Stock immediately following the consummation of this offering. The purchase price of each Pre-funded Warrant is equal to the price per Share being sold t

Later extract: purchase from BioVie Inc., a Nevada corporation (the “ Company ”), up to [*] shares of Common Stock (as subject to adjustment hereunder, the “ Warrant Shares ”). The purchase price of one Warrant Share under this Warrant shall be equal

Earlier extract: Common Stock, par value $0.0001 per share (the “Common Stock”) at an assumed public offering price of $1.33 per Share, the last reported sales price of our Common Stock as reported on The Nasdaq Capital Market (“Nasdaq”) on July 28, 202

Later extract: anization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock reported on the Pink Open Market, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independ

Earlier extract: together with the Shares, the “ Placement Securities ”) to purchase up to [*] shares of Common Stock at an exercise price of $0.0001 per share (the “ Pre-Funded Warrant Shares ” and together with the Placement Securities, the “ Se

Later extract: iates and certain related parties, beneficially owning more than 9.99% of our outstanding shares of Common Stock immediately following the consummation of this offering. The purchase price of each Pre-funded Warrant is equal to the price per Share being sold t

Earlier extract: s ”). The purchase price to the Investors for each Share is $[*] (the “ Share Offering Price ”) and for each Pre-Funded Warrant is $[*], which represents the Share Offering Price less $0.0001. 1. Agreement to Act as Placement Agent; Closing;

Later extract: Common Stock, par value $0.0001 per share (the “Common Stock”) at an assumed public offering price of $1.33 per Share, the last reported sales price of our Common Stock as reported on The Nasdaq Capital Market (“Nasdaq”) on July 28, 202

Earlier extract: the Placement Agent as provided hereunder in connection with the Offering. - 10 - 2.20.3. Use of Proceeds . None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its affiliates, except as specifically authori

Later extract: y 2 The Offering 7 Risk Factors 9 Cautionary Note Regarding Forward-Looking Statements 34 Use of Proceeds 35 Dividend Policy 36 Capitalization 37 Dilution 38 Securities Market Information 39 Business 40 Management’s Discussion and Analysis of Financial C

Earlier extract: ith any primary underwritten public offering for the account of the Company, the managing underwriter(s) thereof shall, in its reasonable discretion, impose a limitation on the number of Shares which may be included in the Registration Statement because, in su

Later extract: 21;), with each Pre-Funded Unit consisting of one pre-funded warrant and one Warrant. The underwriter also exercised its over-allotment option in part and purchased an additional 667,300 Warrants. The Offering resulted in net proceeds of approximately $10.5 mi

Earlier extract: y owning more than 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding shares of Common Stock immediately following the consummation of this offering. The purchase price of each Pre-funded Unit is equal to the price per Unit being sold to th

Later extract: together with the Shares, the “ Placement Securities ”) to purchase up to [*] shares of Common Stock at an exercise price of $0.0001 per share (the “ Pre-Funded Warrant Shares ” and together with the Placement Securities, the “ Se

Earlier extract: ) one warrant to purchase one share of Common Stock (“Warrant”) at an assumed public offering price of $7.55 per Unit, the last reported sale price of our Common Stock as reported on The Nasdaq Capital Market (“Nasdaq”) on July 24, 2025

Later extract: s ”). The purchase price to the Investors for each Share is $[*] (the “ Share Offering Price ”) and for each Pre-Funded Warrant is $[*], which represents the Share Offering Price less $0.0001. 1. Agreement to Act as Placement Agent; Closing;

Earlier extract: 2 The Offering 8 Risk Factors 10 Cautionary Note Regarding Forward-Looking Statements 35 Use of Proceeds 37 Dividend Policy 38 Capitalization 39 Dilution 40 Securities Market Information 42 Business 43 Management’s Discussion and Analysis of Financial Co

Later extract: the Placement Agent as provided hereunder in connection with the Offering. - 10 - 2.20.3. Use of Proceeds . None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its affiliates, except as specifically authori

Earlier extract: 24, 2025. The actual public offering price per Unit will be determined between us and the underwriters at the time of pricing and may be at a discount to this assumed offering price. Therefore, the assumed public offering price used throughout this prospectus

Later extract: ith any primary underwritten public offering for the account of the Company, the managing underwriter(s) thereof shall, in its reasonable discretion, impose a limitation on the number of Shares which may be included in the Registration Statement because, in su